Party's Over

Article

Special Issues

LCGC SupplementsSpecial Issues-07-01-2006
Volume 0
Issue 0

Pharmaceutical marketing and sales folks are now contending within creased government scrutiny of direct-to-consumer advertising and pharma-doctor relationships.

External Link - article-416326.pdf

Articles in this issue
Analytical Instrument Qualification
GMP and Phase I Clinical Trials: Streamlining the Critical Path?
GMP and Phase I Clinical Trials: Streamlining the Critical Path?
Team Effort
Team Effort
Rated PG: Pharmaceutical Guidance Suggested
Rated PG: Pharmaceutical Guidance Suggested
European Clinical Trial Regulations Undergo a Slow Revolution
European Clinical Trial Regulations Undergo a Slow Revolution
A Practical and Cost-Effective Risk Assessment for the Validation of Commercial Laboratory Computerized Systems
A Practical and Cost-Effective Risk Assessment for the Validation of Commercial Laboratory Computerized Systems
Moving Biotech Products from CBER to CDER: A Work in Progress
Moving Biotech Products from CBER to CDER: A Work in Progress
FDA Video Interview Conducted by Jill Wechsler, Washington Bureau Chief
New Climate
New Climate
2006: A Regulatory Odyssey
2006: A Regulatory Odyssey
CDER?s Division of Post-Marketing Evaluation for Quality Assessment
CDER?s Division of Post-Marketing Evaluation for Quality Assessment
Better Compliance Through Technology
Better Compliance Through Technology
Good Clinical Practice Q&A
Good Clinical Practice Q&A
Keeping Pace
Keeping Pace
The Growing Regulatory Burden and Revolution in Global Clinical Trials
The Growing Regulatory Burden and Revolution in Global Clinical Trials
Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Robert Kennedy
Related Content
Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

April 23rd 2024
Article

LCGC International sat down with Jeff Zonderman, senior vice president of Bruker Applied MS at Analytica, to discuss sustainability, PFAS analysis, and the company’s year-old mass spectrometry division.

Ep. 23: Color My World: The Complexities of Color Measurements

Ep. 23: Color My World: The Complexities of Color Measurements

April 1st 2024
Podcast
Site Logo

NanoPak-C All Carbon Solid Phase Extraction (SPE) of Organochlorine Pesticide from Trace Amounts of Environmental Samples

April 23rd 2024
Article

We present a reliable NanoPak-C All Carbon SPE method for extracting and detecting 15 OCPs from small quantities of soil (100 mg) and river water (200 µL) samples.

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

March 7th 2024
Podcast
Powerful Triple Detector for GPC/SEC

Powerful Triple Detector for GPC/SEC

April 22nd 2024
Article
Human liver model on doctor's table, close-up. Treatment of hepatitis, cirrhosis and liver cancer | Image Credit: © Peakstock - stock.adobe.com

Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System

April 22nd 2024
Article

Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.